Scientific work

Prof. Dr. Bülent Karabulut

196 publications. The source of the information is stated next to each publication.

Back to profile

  1. Use of docetaxel in combination with octreotide as a synergistic combination for prostate cancer with apoptotic and antiangiogenic effects.

    Journal of Clinical Oncology, 2014

    DOI 10.1200/jco.2014.32.15_suppl.e13515 Source: OpenAlex

  2. Complications and Toxicities After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

    Annals of Surgical Oncology, 2013

    DOI 10.1245/s10434-012-2853-x PMID 23456387 66 citations (OpenAlex) Source: OpenAlex

  3. Examining the Effect of the Case Management Model on Patient Results in the Palliative Care of Patients With Cancer

    American Journal of Hospice and Palliative Medicine®, 2013

    DOI 10.1177/1049909113506980 PMID 24097840 26 citations (OpenAlex) Source: OpenAlex

  4. Evaluation of the efficacy of adjuvant chemotherapy in patients with high-risk stage II colon cancer.

    PubMed, 2013

    PMID 23818348 9 citations (OpenAlex) Source: OpenAlex

  5. A multi-institutional evaluation of carboplatin plus docetaxel regimen in elderly patients with advanced gastric cancer.

    PubMed, 2013

    PMID 23613400 3 citations (OpenAlex) Source: OpenAlex

  6. Tumor characteristics and metastatic sites may predict bevacizumab efficacy in the first-line treatment of metastatic colorectal cancer

    Molecular and Clinical Oncology, 2013

    DOI 10.3892/mco.2013.212 PMID 24649328 3 citations (OpenAlex) Open-access full textSource: OpenAlex

  7. Survival analysis of metastatic colorectal cancer patients who were treated with the five major therapeutic agents over the course of disease.

    PubMed, 2013

    PMID 24065478 1 citation (OpenAlex) Source: OpenAlex

  8. Paclitaxel in combination with AT-101 induces apoptosis via supressing Bcl-2, bcl-XL, mcl-1 proteins in human breast cancer cells.

    Journal of Clinical Oncology, 2013

    DOI 10.1200/jco.2013.31.15_suppl.e13578 1 citation (OpenAlex) Source: OpenAlex

  9. Üçlü-Negatif Meme Kanserli Hastalarda Güncel Klinik Uygulamalar ve Devam Eden Klinik Çalışmalar

    Turkiye Klinikleri General Surgery - Special Topics, 2013

    Source: OpenAlex

  10. Kolorektal Kanser Tedavisinde Hedefe Yönelik Ajanlar ve Uygulama Alanları

    Turkiye Klinikleri Medical Oncology - Special Topics, 2013

    Source: OpenAlex

  11. Metastatik Küçük Hücreli Dışı Akciğer Kanserinde İdame Tedavinin Yeri

    Turkiye Klinikleri Medical Oncology - Special Topics, 2013

    Source: OpenAlex

  12. Comparison of Survival of Colorectal Cancer Patients Undergone for Metastasectomy Before or After Chemotherapy with Liver Only Metastases

    Annals of Oncology, 2013

    DOI 10.1093/annonc/mdt203.225 Open-access full textSource: OpenAlex

  13. Interpreting Genomic Diversity for Breast Cancer: Molecular Subtypes of Breast Cancer in Very Young Women (≤35 Y) in Western Turkey

    Annals of Oncology, 2013

    DOI 10.1093/annonc/mdt078.5 Open-access full textSource: OpenAlex

  14. Do Tumour Characteristics and Disease Localization Predict Bevacizumab Activity in the Treatment of Metastatic Colorectal Cancer?

    Annals of Oncology, 2013

    DOI 10.1093/annonc/mdt203.196 Open-access full textSource: OpenAlex

  15. Fluorouracil and folinic acid bolus schedule (nordic regimen) combined with irinotecan as a first-line chemotherapy in metastatic colorectal cancer

    DergiPark (Istanbul University), 2013

    Source: OpenAlex

  16. Capecitabine maintenance therapy after docetaxel/capecitabine combination chemotherapy in patients with metastatic breast cancer.

    Journal of Clinical Oncology, 2013

    DOI 10.1200/jco.2013.31.15_suppl.e12018 Source: OpenAlex

  17. Understanding international genomic diversity for breast cancer: Comparison of molecular subtypes of breast cancer in very young women (age ≤ 35) between Izmir (Western Turkey) and Boston (Massachusetts, USA).

    Journal of Clinical Oncology, 2013

    DOI 10.1200/jco.2013.31.15_suppl.e12509 Source: OpenAlex

  18. Combination of AT-101/cisplatin overcomes chemoresistance by inducing apoptosis and modulating epigenetics in human ovarian cancer cells

    Molecular Biology Reports, 2012

    DOI 10.1007/s11033-012-2469-z PMID 23269627 42 citations (OpenAlex) Source: OpenAlex

  19. Pretreatment with AT-101 enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of breast cancer cells by inducing death receptors 4 and 5 protein levels

    Journal of Cancer Research and Clinical Oncology, 2012

    DOI 10.1007/s00432-012-1187-1 PMID 22411600 23 citations (OpenAlex) Open-access full textSource: OpenAlex

  20. Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone‐refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A

    British Journal of Urology, 2012

    DOI 10.1111/j.1464-410x.2012.11392.x PMID 22882676 16 citations (OpenAlex) Source: OpenAlex

  21. The Frequency and Significance of Radiologically Detected Indeterminate Pulmonary Nodules in Patients with Colorectal Cancer

    Medical Principles and Practice, 2012

    DOI 10.1159/000337426 PMID 22572176 17 citations (OpenAlex) Open-access full textSource: OpenAlex

  22. Comparing Time to Disease Progression of Irinotecan and Oxaliplatin-based Chemotherapies in Colorectal Cancer Patients With Liver Only Metastasis

    American Journal of Clinical Oncology, 2012

    DOI 10.1097/coc.0b013e318248da7c PMID 22643568 6 citations (OpenAlex) Source: OpenAlex

  23. 98P Octreotide in Combination with Docetaxel Triggers Apoptosis by Inducing Sstr2 and Sstr5 Levels in Human Breast Cancer Cells, Mcf-7 and Mda-Mb-231

    Annals of Oncology, 2012

    DOI 10.1016/s0923-7534(19)65742-x 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  24. 52 Examining the Effect of the Case Management Model on Patient Results in the Palliative Care of Cancer Patients

    European Journal of Oncology Nursing, 2012

    DOI 10.1016/s1462-3889(12)70067-4 1 citation (OpenAlex) Source: OpenAlex

  25. 99P Zoledronic Acid in Combination with Serine/Threonine Phosphatase Inhibitors Induces Cytotoxicity and Apoptosis in Human Breast Cancer Cells via Decreasing the Activities of Pp1 and Pp2A

    Annals of Oncology, 2012

    DOI 10.1016/s0923-7534(19)65743-1 Open-access full textSource: OpenAlex

  26. 94P Comparison of A Novel, Label-Free, and Real-Time cell Based System (Xcelligence) With a Conventional Viability Assay (Xtt) to Determine the Anti-Proliferative Effect of At-101 in Human Breast Cancer Cells

    Annals of Oncology, 2012

    DOI 10.1016/s0923-7534(19)65737-6 Open-access full textSource: OpenAlex

  27. Front & Back Matter

    Medical Principles and Practice, 2012

    DOI 10.1159/000342183 Open-access full textSource: OpenAlex

  28. p53 Protein Accumulation and Presence of Visceral Metastasis Are Independent Prognostic Factors for Survival in Patients with Metastatic Inflammatory Breast Carcinoma

    Medical Principles and Practice, 2011

    DOI 10.1159/000319916 PMID 21252573 5 citations (OpenAlex) Open-access full textSource: OpenAlex

  29. Targeting Bcl-2 Protein to Enhance Chemosensitivity of Hormone Refractory Prostate Cancer Cell Line, DU-145 by a Synergistic Combination of Docetaxel and Gossypol

    Turkiye Klinikleri Journal of Medical Sciences, 2011

    DOI 10.5336/medsci.2010-19849 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  30. Kolon Kanserinin Farmakogenetiği

    Turkiye Klinikleri Medical Oncology - Special Topics, 2011

    Source: OpenAlex

  31. Liposomal Doxorubicin-Related Palmar-Plantar Erthrodysesthesia (Hand-And Foot Syndrome): Report Of A Case

    Journal of Turkish Society of Obstetric and Gynecology, 2011

    DOI 10.5505/tjod.2011.87059 Open-access full textSource: OpenAlex

  32. Zoledronik asit in protein fosfataz inhibitörleri ile kombinasyonunun insan hormon refrakter prostat kanser kanseri hücrelerinde farnesilprofosfat sentaz üzerine etkilerinin araştırılması

    Çanakkale Onsekiz Mart University AVESIS, 2011

    Source: OpenAlex

  33. Prostat kanseri hücre hatlarında zoledronik asit uygulamasının sitotoksik ve anti anjiogenik etkilerinin araştırılması

    Çanakkale Onsekiz Mart University AVESIS, 2011

    Source: OpenAlex

  34. Comparison of XTT and Alamar blue assays in the assessment of the viability of various human cancer cell lines by AT-101 (−/− gossypol)

    Toxicology Mechanisms and Methods, 2010

    DOI 10.3109/15376516.2010.508080 PMID 20843265 40 citations (OpenAlex) Source: OpenAlex

  35. Regulation of apoptosis-related molecules by synergistic combination of all-trans retinoic acid and zoledronic acid in hormone-refractory prostate cancer cell lines

    Molecular Biology Reports, 2010

    DOI 10.1007/s11033-010-0102-6 PMID 20349282 19 citations (OpenAlex) Source: OpenAlex

  36. Enhancing cytotoxic and apoptotic effect in OVCAR-3 and MDAH-2774 cells with all-trans retinoic acid and zoledronic acid: a paradigm of synergistic molecular targeting treatment for ovarian cancer

    Journal of Experimental & Clinical Cancer Research, 2010

    DOI 10.1186/1756-9966-29-102 PMID 20673323 22 citations (OpenAlex) Open-access full textSource: OpenAlex

  37. Palliative Care Activity in the field of Oncology in Turkey

    Journal of Palliative Care, 2010

    DOI 10.1177/082585971002600408 PMID 21268524 13 citations (OpenAlex) Source: OpenAlex

  38. Radiosensitization of hormone-refractory prostate cancer cells by gossypol treatment.

    PubMed, 2010

    PMID 21229643 9 citations (OpenAlex) Source: OpenAlex

  39. Apoptosis-Mediated Cytotoxic Effects of Ibandronic Acid on Hormone- and Drug-Refractory Prostate Cancer Cells and Human Breast Cancer Cells

    Journal of International Medical Research, 2010

    DOI 10.1177/147323001003800511 PMID 21309480 2 citations (OpenAlex) Source: OpenAlex

  40. Bisphosphonate (Zoledronic Acid) Associated Adverse Events: Single Center Experience

    2010

    4 citations (OpenAlex) Source: OpenAlex

  41. PP291 TAC REGIMEN INDUCED METABOLIC SYNDROME-X IN BREAST CANCER PATIENTS

    Clinical Nutrition Supplements, 2010

    DOI 10.1016/s1744-1161(10)70366-5 Source: OpenAlex

  42. İnsan meme kanseri hücre hatlarında AT 101 trail kombinasyonunun sitotoksik ve apoptotik etkilerinin araştırılması

    Çanakkale Onsekiz Mart University AVESIS, 2010

    Source: OpenAlex

  43. Can hyperbaric oxygenation decrease doxorubicin hepatotoxicity and improve regeneration in the injured liver?

    Journal of Hepato-Biliary-Pancreatic Surgery, 2009

    DOI 10.1007/s00534-009-0059-9 PMID 19288285 2 citations (Europe PMC) Source: OpenAlex

  44. Overcoming drug resistance in hormone- and drug-refractory prostate cancer cell line, PC-3 by docetaxel and gossypol combination

    Molecular Biology Reports, 2009

    DOI 10.1007/s11033-009-9501-y PMID 19288219 34 citations (OpenAlex) Source: OpenAlex

  45. Combined gossypol and zoledronic acid treatment results in synergistic induction of cell death and regulates angiogenic molecules in ovarian cancer cells

    European Cytokine Network, 2009

    DOI 10.1684/ecn.2009.0159 PMID 19825521 26 citations (OpenAlex) Source: OpenAlex

  46. Regulation of growth factors in hormone‐ and drug‐resistant prostate cancer cells by synergistic combination of docetaxel and octreotide

    British Journal of Urology, 2009

    DOI 10.1111/j.1464-410x.2009.08340.x PMID 19191785 22 citations (OpenAlex) Source: OpenAlex

  47. Efficacy and safety of bevacizumab plus capecitabine and irinotecan regimen for metastatic colorectal cancer

    Medical Oncology, 2009

    DOI 10.1007/s12032-009-9253-5 PMID 19526201 15 citations (OpenAlex) Source: OpenAlex

  48. The effect of racemic gossypol and at-101 on angiogenic profile of ovcar-3 cells: a preliminary molecular framework for gossypol enantiomers.

    PubMed, 2009

    PMID 20010531 13 citations (OpenAlex) Open-access full textSource: OpenAlex

  49. Enhancement of taxane-induced cytotoxicity and apoptosis by gossypol in human breast cancer cell line MCF-7.

    PubMed, 2009

    PMID 19810142 11 citations (OpenAlex) Source: OpenAlex

  50. Palliative radiotherapy for the skin metastasis of ovarian cancer: a case report and review of the literature

    Medical Oncology, 2009

    DOI 10.1007/s12032-009-9259-z PMID 19536657 12 citations (OpenAlex) Source: OpenAlex